Lisa Walker

7.2k citations

52 papers · 5.4k · 3 hit papers · h-index 29

Impact in

Genetics top 0.5%
- BRCA gene mutations in cancer
- Genetic Associations and Epidemiology
Cancer Research top 2%
- Cancer Genomics and Diagnostics

Papers in

Genetics 26
- BRCA gene mutations in cancer 23
- Nutrition, Genetics, and Disease 4
- Genomic variations and chromosomal abnormalities 3
- Genetic Associations and Epidemiology 3
Cancer Research 4

Co-authors: Fredrik Karpe (2 shared papers)Michael J.O. Wakelam (2 shared papers)Jonathan Cummings Levy (2 shared papers)Martijn van de Bunt (2 shared papers)Anna L. Gloyn (2 shared papers)Thomas M. Barber (2 shared papers)Katherine L. Lachlan (2 shared papers)Simon A. Rudge (2 shared papers)
Journals: Cancer Epidemiology Biomarkers & Prevention (5 papers)European Urology (4 papers)Nature Genetics (3 papers)JNCI Journal of the National Cancer Institute (2 papers)Genetics in Medicine (2 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Lisa Walker

50 papers receiving 5.3k citations

Lisa Walker's Hit Papers

align trajectories log scale

Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer 2015 · 397 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2015 JAMA
2013 JNCI Journal of the National Cancer Institute
2012 Cancer Epidemiology Biomarkers & Prevention

Peers

Countries citing papers authored by Lisa Walker

Since Specialization

Citations

This map shows the geographic impact of Lisa Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Walker more than expected).

Fields of papers citing papers by Lisa Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Walker. The network helps show where Lisa Walker may publish in the future.

Co-authors

The 25 scholars most cited alongside Lisa Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lisa Walker Line = papers co-authored together Lisa Walker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE JNCI Journal of the National Cancer Institute ·Nasim Mavaddat, Susan Peock, Debra Frost, Radka Platte, Elena Fineberg, D. Gareth Evans, Louise Izatt, Rosalind A. Eeles Hit paper breakdown →	2013	718
2	Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA) Cancer Epidemiology Biomarkers & Prevention ·Nasim Mavaddat, Daniel Barrowdale, Irene Louise Andrulis, Susan M. Domchek, Diana M. Eccles, Heli A. Nevanlinna, Susan J. Ramus, Amanda B. Spurdle Hit paper breakdown →	2012	529
3	Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Nature Genetics ·Australian Cancer Study, Stig Bojesen, Australian Ovarian Cancer Study, Gene Environment Interaction and Breast Cancer (GENICA), Swedish Breast Cancer Study (SWE-BRCA), Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE), Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO), Karen A. Pooley	2013	463
4	Germline mutations in RAD51D confer susceptibility to ovarian cancer Nature Genetics ·Chey Loveday, Clare Turnbull, Emma Ramsay, Deborah Hughes, Elise Ruark, Jessica R. Frankum, Georgina R. Bowden, Bolot Kalmyrzaev	2011	421
5	Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer JAMA ·Timothy R. Rebbeck, Nandita Mitra, Fei Wan, Olga M. Sinilnikova, Sue C. Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix‐Trench Hit paper breakdown →	2015	397
6	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer Nature Genetics ·Roger Laughlin Milne, Karoline B. Kuchenbaecker, K Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar, Sara Lindström, Shirley Hui, Audrey Lemaçon	2017	298
7	Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations Human Mutation ·Timothy Richard Rebbeck, Tara M. Friebel, Eitan Friedman, Ute Hamann, Dezheng Huo, Ava Ki-Wa Tin. Kwong, Edith Oláh, Olufunmilayo Ibironke Olopade	2018	242
8	Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer Nature ·Elise Ruark, Katie M.G. Snape, Peter Humburg, Chey Loveday, Ilirjana Bajrami, Rachel Brough, Daniel Nava Rodrigues, Anthony Renwick	2012	209
9	Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study European Urology ·Elizabeth Kathryn Bancroft, Elizabeth C. Page, Elena Castro, Hans G. Lilja, Andrew Julian Vickers, Daniel D. Sjoberg, Melissa J. Assel, Christopher S. Foster	2014	198
10	PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity New England Journal of Medicine ·Aparna Pal, Thomas M. Barber, Martijn van de Bunt, Simon A. Rudge, Katherine L. Lachlan, Nicola S. Cooper, Helen Linden, Jonathan Cummings Levy	2012	190
11	Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers European Urology ·Elizabeth C. Page, Elizabeth Kathryn Bancroft, Mark N. Brook, Melissa J. Assel, Mona Hassan Al Battat, Sarah Ann Thomas, Natalie Jayne Taylor, Anthony Chamberlain	2019	184
12	Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study European Urology ·Tommy Nyberg, Debra Frost, Daniel Barrowdale, D. Gareth Evans, Elizabeth Kathryn Bancroft, Julian Adlard, Munaza Ahmed, Julian Barwell	2019	175
13	Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction Cancer Research ·Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog, Olga M. Sinilnikova, Sue C. Healey, Susan L. Neuhausen, Yuan Chun Ding, Timothy R. Rebbeck	2010	151
14	Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores Journal of Clinical Oncology ·Julie Lecarpentier, Valentina Silvestri, Karoline B. Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie	2017	139
15	DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers PLoS Genetics ·Ana Osório, Roger Laughlin Milne, Karoline B. Kuchenbaecker, Tereza Vaclová, Guillermo Pita, Rosario Alonso, Paolo Peterlongo, Ignacio Blanco	2014	105
16	Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants Genetics in Medicine ·Daniel R. Barnes, Matti A. Rookus, Lesley McGuffog, Goska Leslie, Thea M. Mooij, Joe Dennis, Nasim Mavaddat, Julian Adlard	2020	93
17	Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH‐B) gene mutation carriers Clinical Endocrinology ·Umasuthan Srirangalingam, Lisa Walker, Bernard Chong Eu Khoo, Fiona MacDonald, Daphne Su-Lyn Gardner, Terence J. Wilkin, Rob Skelly, Emad George	2008	76
18	Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers Breast Cancer Research ·Antonis C. Antoniou, Karoline B. Kuchenbaecker, Penny Soucy, Jonathan Beesley, Lesley McGuffog, Andrew S. Lee, Daniel Barrowdale, Sue C. Healey	2012	75
19	Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus Nature Communications ·Kate Lawrenson, Siddhartha Kar, Karen McCue, Karoline Kuchenbaeker, K Kyriaki Michailidou, Jonathan P. Tyrer, Jonathan Beesley, Susan J. Ramus	2016	67
20	The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine PLoS ONE ·Hayley C. Whitaker, Zsofia Kote‐Jarai, Helen Ross‐Adams, Anne Yvonne Warren, Johanna Burge, Anne George, Elizabeth Kathryn Bancroft, Sameer G. Jhavar	2010	63

About Lisa Walker

Lisa Walker is a scholar working on Genetics, Cancer Research, Pediatrics, Perinatology and Child Health, Molecular Biology and Oncology, having authored 52 papers that have together received 5.4k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (23 papers), Nutrition, Genetics, and Disease (4 papers), DNA Repair Mechanisms (4 papers), Adrenal and Paraganglionic Tumors (4 papers), Genomic variations and chromosomal abnormalities (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Genetic Associations and Epidemiology (3 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Genetics (2.6k citations), Cancer Research (1.1k citations), Reproductive Medicine (486 citations), Oncology (1.0k citations) and Pathology and Forensic Medicine (533 citations). Lisa Walker has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Fredrik Karpe, Michael J.O. Wakelam, Jonathan Cummings Levy, Martijn van de Bunt, Anna L. Gloyn, Thomas M. Barber, Katherine L. Lachlan, Simon A. Rudge, Nicola S. Cooper and Aparna Pal. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, European Urology, Nature Genetics, JNCI Journal of the National Cancer Institute and Genetics in Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Lisa Walker

Impact in

Papers in i

In The Last Decade

Lisa Walker

Lisa Walker's Hit Papers

Peers

Countries citing papers authored by Lisa Walker

Fields of papers citing papers by Lisa Walker

All Works

About Lisa Walker

Explore authors with similar magnitude of impact

Papers in